Picture of Precigen logo

PGEN — Precigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Precigen Inc reports results for the quarter ended in September - Earnings Summary

* Precigen Inc  PGEN.OQ  reported a quarterly adjusted loss
of 4
cents​​ per share for the quarter ended in September. The mean
expectation of three analysts for the quarter was for earnings
of 2 cents per share.
    * Revenue fell 22.4% to $16.72 million from a year ago;
analysts
expected $35.31 million. 
    * Precigen Inc's reported EPS for the quarter was 44 cents​.
    * The mean earnings estimate of analysts had risen by
about 211.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Precigen Inc shares had fallen by 24.5% this quarter and
lost 56.9% so far this year.
    * The company reported quarterly net income of $87.38
million.
    * Wall Street's median 12-month price target for Precigen
Inc is
$13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.02           -0.04          Missed
 Jun. 30 2022      -0.13          -0.09          Beat
 Mar. 31 2022      -0.13          -0.10          Beat
 Dec. 31 2021      -0.14          -0.13          Beat

Recent news on Precigen

See all news